Standout Papers

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Rece... 1998 2026 2007 2016 509
  1. erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer (1998)
    Soonmyung Paik, John Bryant et al. JNCI Journal of the National Cancer Institute

Immediate Impact

18 by Nobel laureates 16 from Science/Nature 97 standout
Sub-graph 1 of 20

Citing Papers

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
3 intermediate papers

Works of David M. Hyams being referenced

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
2011

Author Peers

Author Last Decade Papers Cites
David M. Hyams 1498 522 428 36 2.0k
Allan Topham 1162 324 675 25 2.5k
Ian Kennedy 1673 389 270 20 2.2k
J Richard 1174 519 465 38 2.0k
Friedrich Prall 1439 579 466 77 2.4k
George J. Olt 762 659 492 38 2.2k
James Pettay 888 302 691 43 1.8k
Marta Guix 1253 322 1090 42 2.2k
S Hirohashi 591 582 706 54 2.5k
D. Schultz 1044 293 380 28 2.3k
Jörg Nährig 638 353 627 50 2.1k

All Works

Loading papers...

Rankless by CCL
2026